Reduction in venous thromboembolism by agents affecting platelet function

N Engl J Med. 1971 Jun 10;284(23):1287-92. doi: 10.1056/NEJM197106102842303.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Arthroplasty
  • Aspirin / adverse effects
  • Aspirin / pharmacology
  • Aspirin / therapeutic use*
  • Blood Platelets / drug effects*
  • Chromium Alloys
  • Dextrans / adverse effects
  • Dextrans / pharmacology
  • Dextrans / therapeutic use*
  • Dipyridamole / adverse effects
  • Dipyridamole / pharmacology
  • Dipyridamole / therapeutic use*
  • Female
  • Hemorrhage / etiology
  • Hip / surgery
  • Humans
  • Joint Prosthesis
  • Male
  • Middle Aged
  • Platelet Adhesiveness / drug effects
  • Postoperative Complications / prevention & control
  • Pulmonary Embolism / prevention & control
  • Thromboembolism / prevention & control*
  • Thrombophlebitis / prevention & control
  • Veins
  • Warfarin / adverse effects
  • Warfarin / therapeutic use

Substances

  • Chromium Alloys
  • Dextrans
  • Warfarin
  • Dipyridamole
  • Aspirin